Amend Surgical

Amend Surgical is a product development company focused on biomaterial innovations for the dental market.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Gainesville, FL, USA
  • Currency USD
  • Founded June 2015
  • Employees 8
  • Incorporation Type C-corp
  • Website amendsurgical.com

Company Summary

Amend Surg. is focused on the development and commercialization of novel materials for the oral surgical and dental market. In 2020, we licensed the exclusive rights for a novel adhesive for dental and oral surgical applications from Harvard University. The wound and barrier technology forms long lasting ionic and covalent bonds that tightly interconnect our adhesive to biologic tissue, even in challenging wet environments like the oral cavity.

Team

  • Robert Lane
    CEO and Co-founder.

    Has worked for over 25 years in the medical device and biologics fields. He was President and Managing Director at Tutogen Medical in Neunkirchen, Germany where he led the financial and global market expansion of this division of RTI Surgical. Most recently, he worked as Executive Vice President of Commercial Distribution at RTI Surgical where he drove product development and the exponential expansion of the company’s commercial partnerships.

  • Ronald Cobb
    Co-founder

    Has worked for over 20 years in the pharmaceutical and medical device fields. While he was Director of Research at RTI Biologics, over 20 new products and line extensions were launched. Ron is currently Chief Scientific Officer at Nanotherapuetics, Inc., focusing on the R&D and Manufacturing of various vaccine and recombinant protein pharmaceutics

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free